ZYN Melts Launch, FDA Approval Review and Canada's Pouch Stand: News Roundup

Three stories moved the nicotine pouch world in the last two weeks: a new dissolvable format from ZYN, a regulatory rethink at the US FDA and a firm "no" from Canada's health minister. None of them changes what you can order in the EU today, but together they show where the market is heading. Here is the plain-English version, with sources, and what it means for your wallet.

ZYN Melts: A New Format Arrives

Philip Morris International has launched ZYN Melts, a fully dissolvable oral nicotine tablet, in the UK and Switzerland. According to 2Firsts, the UK range has four products: Cool Mint and Peppermint, each in 1 mg and 2 mg. A can holds 20 tablets and costs £6.50 in the UK, while the Swiss price is CHF 5.90.

The tablet sits between the upper lip and gum and dissolves completely, so there is nothing to remove or bin afterwards. Tobacco Insider reports that it dissolves in about 7 to 8 minutes and describes it as zero-waste. ZYN's UK site says Melts are not marketed as a smoking-cessation aid.

How Melts Compare With Pouches

For most regular users, a 1 to 2 mg tablet is a light, short hit rather than a replacement for a stronger pouch. If you want a long-lasting session, a classic pouch is still the better choice. Browse our light nicotine pouches for gentle options with a longer session.

Why New Formats Matter

ZYN Melts show how big brands are widening the category beyond the classic pouch. A tablet that dissolves leaves no used product behind, which tackles one of the common complaints about pouches: what to do with the waste. It also targets a lighter, shorter use occasion, such as a quick hit between meetings.

For shoppers, the practical question is simple. Do you want a short, light tablet, or a longer-lasting pouch you control yourself? Many regular users will stay with pouches because they can pick the strength, flavour and format they like, from slim to mini, and dry to moist. Our guide to dry vs moist nicotine pouches is a good place to start if you are still deciding.

FDA: A Rethink of the Approval Rules

On 23 September, the Wall Street Journal reported, as summarised by Reuters, that the FDA was expected to revisit a 2021 rule on new tobacco product applications. The possible changes included simpler scientific study requirements and shorter review times. Reuters said it could not immediately verify the report.

The agency then confirmed the review. Tobacco Journal reports that the FDA's statement of 28 September said it is evaluating changes to its PMTA framework, citing its experience with the 2021 rule, court developments, the growth of the illicit market and the pace of new product introductions. It also stressed that no immediate operational changes are being introduced and that reviews will continue under current requirements.

What It Could Mean

• More authorised products over time. A faster process could bring more pouches onto the legal US market.
• More competition. More brands usually mean more choice and sharper prices.
• No change in the EU. This is a US process and does not alter EU rules.

For background, read our guides on FDA nicotine pouch approvals in 2026 and ZYN's FDA modified-risk authorisation.

Canada: No Plans to Loosen the Rules

On 23 September, Canada's Federal Health Minister Marjorie Michel said she was not considering changes to the rules that restrict pouch sales. According to the Canadian Press report, her words were "That's not something I'm considering."

In Canada, pouches are regulated as an aid to quit smoking, sold only to adults and kept behind the counter at pharmacies. The report says only one brand, Zonnic, has been approved since 2024, in 4 mg pouches. Michel acknowledged that illicit and online sales, including brands such as ZYN, are hard to track, while tobacco-control groups called for tougher enforcement. Tobacco Reporter adds that Unsmoke Canada, part of PMI's Rothmans, Benson and Hedges business, had campaigned for retail-store sales. Our Canada guide explains the background.

The EU: Still Stuck in Debate

There is no new EU-wide rule this week. Tobacco Intelligence's briefing lists a headline on 29 September that MEPs urged tighter regulation of novel nicotine products, including pouches, and one on 1 October on the stalled EU tobacco taxation reform. Tobacco Insider reported earlier that member states were deadlocked over minimum tax rates and market access, and unlikely to agree before December 2026. For the wider picture, see our October 2026 news roundup.

Big Tobacco Keeps Betting on Pouches

BAT used its Capital Markets Day to set out its Horizon 2030 plan. According to Tobacco Insider, the company targets mid-teens compound annual revenue growth in its New Categories portfolio through 2030, with a contribution margin of at least 30%. PMI, for its part, is building out ZYN with new formats. The takeaway: the big players are pushing harder, which keeps the market competitive.

How to Read Regulatory News Without the Panic

Headlines often sound bigger than the reality. A short checklist helps you decide whether a story matters to your next order:

1. Is it law yet? A review, a draft or a parliamentary vote is not the same as an adopted rule.
2. Where does it apply? A US, Canadian or Indian decision has no direct effect on an EU delivery.
3. When would it start? Most rules come with transition periods that give retailers and customers time to adjust.
4. Who is saying it? Prefer regulators and wire services over social media rumours.

Using that checklist, this week's stories fall firmly in the "watch, but do not panic" bucket. The FDA said no immediate operational changes are being introduced, Canada is keeping its current rules and the EU debate is unresolved.

Quick Summary: What Changed and What It Means

What This Means for Your Next Order

Nothing here forces you to change your habits, and EU rules are not moving this week. If you use pouches daily, ordering in bulk is still the cheapest way to buy, and orders over €99 ship free within the EU. Check out the popular ranges from VELO, LOOP, C.R.E.A.M, ZEUS, XQS and KUMA, or grab a bargain in our outlet deals.

Should You Wait for New Products?

There is no need to wait. New formats and approvals take months to reach shelves, and they may never arrive in your country. Meanwhile, the pouches you already know are available now, often at lower prices than new launches. If you do want to experiment, start with a single can of something new and keep your usual strength as a reference.

It is also worth remembering that pouches contain nicotine, which is addictive. They are for adults who already use nicotine, and they are not a reason to start.

FAQ: This Week's Nicotine Pouch News

What are ZYN Melts?

They are dissolvable nicotine tablets from PMI, available in 1 mg and 2 mg Cool Mint and Peppermint. They dissolve under the upper lip, so there is nothing to remove.

Are ZYN Melts available in the EU?

Reports so far cover the UK and Switzerland. We have not seen EU availability confirmed.

Has the FDA changed its rules yet?

No. The FDA said it is evaluating changes and that no immediate operational changes are being introduced.

Is Canada loosening its nicotine pouch rules?

No. The health minister said on 23 September that loosening the rules is not something she is considering.

Do these stories affect my EU order?

No. None of them changes EU rules or what we ship within the EU.

Final Thoughts

The pouch world is evolving fast, with new formats, shifting US rules and tough talk elsewhere, but EU shoppers still enjoy a wide range at competitive prices. Stock up on your favourites in the best nicotine pouches of 2026 collection and get free EU shipping on orders over €99.